The relationship of tri-O-cresyl-phosphate (78308) (TOCP) induced delayed neurotoxicity to the enhancement of in-vitro brain and spinal cord protein phosphorylation was studied in hens and rats, to investigate organophosphorus compound induced delayed neurotoxicity (OPIDN). Adult leghorn-hens were treated with single oral doses of 750mg/kg TOCP, 837mg/kg of leptophos (21609905), 750mg/kg tri-p- cresyl-phosphate (78320) (TPCP), or 5mg/kg parathion (56382). Male Sprague-Dawley-rats received 750mg/kg TOCP by gavage for study of species effects. After 21 days, in-vitro protein phosphorylation was determined in subcellular fractions from hen brains and spinal cords. The TOCP dose was correlated with neurologic deficit and calcium ion dependence of phosphorylation. The non OPIDN producing organophosphorus compounds TPCP and parathion had no effect on phosphorylation or clinical condition. Hens given leptophos developed more severe delayed neurological deficit, earlier than those given TOCP; phosphorylation was increased significantly. Young chicks and adult rats given the same treatment as the hens did not show signs of OPIDN or significant change in phosphorylation. Results suggest the involvement of calcium dependent brain protein phosphorylation in the etiology of OPIDN.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.